Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 December 2021 | Story Lacea Loader

The Council of the University of the Free State (UFS) approved the retirement age of all staff members to 65 this week. 

“The current retirement age for staff members of the UFS is 65 years for those appointed prior to 1 June 1998, and 60 years for those appointed after 1 June 1998. The Council’s decision to amend the retirement age to 65 comes after an extensive benchmarking process involving the university’s two labour unions, NEHAWU and UVPERSU, which requested that the retirement age of all staff members be adjusted to 65,” said Prof Francis Petesen, UFS Rector and Vice-Chancellor.

 This amendment brings the university in line with other universities and will assist in overcoming a negative impact on the recruitment and attraction of high-calibre academic and specialist staff.

 Parallel to the amendment of the retirement age in the Conditions of Services, the university is also adapting the allocation of vacation leave. “We are currently facing a challenge in terms of the provision of the staff leave liability, which has a major financial implication for the UFS. In consultation with stakeholder unions the accumulation of vacation leave has been adjusted to a maximum of five days per year,” said Prof Petersen.

 The new retirement age to 65 and the adjusted accumulated vacation leave days will be affected from 1 January 2022. Staff who are set to retire on 31 December 2021 may opt to continue to the age 65. This amendment will not apply to staff that may have already retired.

Adjusted vacation as from 1 January 2022:

Academic staff:

Current number of vacation days: 42 
Approved Leave Days
Number of vacation days: 30
Additional research leave days: 12 (non-cumulative and expires at the end of each calendar year)

Support staff:

Deputy Director and higher levels
Peromnes Level: 1 – 6
Current number of leave vacation days: 36
Approved number of vacation days: 30

Assistant Director to Officer
Peromnes Level: 7 – 14
Current number of leave vacation days: 30 - 28
Approved number of vacation days: 28

Service Workers 
Peromnes Level: 15 - 18
Current number of leave vacation days: 24
Approved number of vacation days: 24

 

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept